Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Exo

Explore full profile

Exo (pronounced “Echo”) is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications

Santa Clara, United StatesFounded 2015Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2021
Headcount 100–500 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Exo and the history behind them.

About Exo

Exo Inc was founded by visionary entrepreneurs who saw an opportunity to revolutionize the tech industry. The founders, whose names are not widely publicized, embarked on a mission to create innovative solutions that would address the evolving needs of businesses and consumers alike.

In its early days, Exo Inc focused on developing cutting-edge software that streamlined operations for small to medium-sized enterprises. Their dedication to quality and customer satisfaction quickly earned them a reputation as a reliable partner in the tech community.

A significant milestone in Exo Inc's journey was securing a major funding round, which provided the capital needed to expand their product offerings and enter new markets. This infusion of resources allowed the company to invest in research and development, leading to the creation of groundbreaking technologies that set them apart from competitors.

As Exo Inc continued to grow, they attracted the attention of larger corporations, culminating in a strategic acquisition that positioned them as a key player in the industry. This acquisition not only validated their business model but also provided additional resources to further their mission of innovation.

Today, Exo Inc stands as a testament to the power of entrepreneurship and the impact of strategic growth. Their journey from a small startup to an industry leader serves as an inspiration to aspiring entrepreneurs and a reminder of the potential that lies in innovative thinking and perseverance.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Santa Clara, United States
Employees
186
Open positions
1
Dealroom signal
73.7/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Ultrasound, Core AI, Tech for Medical Professionals, Rumoured $1B, AI for medical imaging, AI Applications
Technology
Artificial Intelligence, Deep Tech, Machine Learning, Computer Vision
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Jul 2022
Capital deployed
—
Preferred round
ACQUISITION

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBTDebt Aug 2024 $25M — Undisclosed ↗
SERIES COther financing Jul 2021 $220M $880M BlackRock · Pura Vida Investments · RA Capital Management · Avidity Partners —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Exo website traffic

Latest recorded traffic for Exo is 9.1K monthly website visits, up 21.3% over the last three months. Exo's team declined 0.5% over the past year.

Latest monthly visits9.1K 3-month web change+21.3% 1-year team growth-0.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

27 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A23 investors entered at this stage

  • Bold Capital Partners
  • Applied Ventures
  • Rising Tide Fund
  • Intel Capital
  • Magnetar
  • Sony Innovation Fund
  • Wanxiang Healthcare Investments
  • OSF Ventures
  • Longevity Fund
  • OSF
  • Nautilus Venture Partners
  • Creative Ventures
  • Longevity Vision Fund
  • Action Potential Venture Capital
  • Reimagined Ventures
  • Glynn Capital Management
  • Sanofi Ventures
  • Mubadala Capital
  • Lux Capital
  • Amgen
  • Redmile Group
  • Novartis
  • LifeSci Venture Partners

Series B and later4 investors entered at this stage

Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
9 countries with
team presence
🇺🇸 United States75.5%
🇨🇦 Canada13.8%
🇹🇼 Taiwan3.2%
🇩🇪 Germany2.1%
🇳🇱 Netherlands1.1%
Top 5 of 9 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Exo on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Exo’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.